about
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the ...
Read More
2.48
0.10
(4.20%)
4.3M
XNAS Volume
XNAS 09 Dec, 2025 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Invivyd Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..